Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801616 · ClinicalTrials.gov registry record · NA
Virtual Reality After Breast Reconstruction Surgery
A NA study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03801616 is a NA study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 45 participants.
The verdict
NCT03801616, a NA study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a pilot study of virtual reality (VR) non-opioid management for women undergoing mastectomy and implant-based reconstruction. Study participants will receive specialized VR interventions, administered via VR headsets, to manage pain.
Interventions
- DEVICE Virtual Reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2020-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801616
The ClinicalTrials.gov registry entry for NCT03801616 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality is the first listed.
NCT03801616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801616 about?
NCT03801616 is a clinical study titled "Virtual Reality After Breast Reconstruction Surgery". This is a pilot study of virtual reality (VR) non-opioid management for women undergoing mastectomy and implant-based reconstruction. Study participants will receive specialized VR interventions, administered via VR headsets, to manage pain.
What is the current status of trial NCT03801616?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2019-01-30. Estimated completion is 2020-06-04.
What interventions are being tested in trial NCT03801616?
The interventions under investigation include: Virtual Reality (DEVICE).
Who is sponsoring clinical trial NCT03801616?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.